Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
June 20, 2018 12:03 ET
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
June 20, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
February 27, 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
February 27, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution...
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
January 30, 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors
January 11, 2018 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
December 18, 2017 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Scott VanderWel Joins PCI Synthesis as Business Development Manager
November 15, 2017 10:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Qu Biologics recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team
November 08, 2017 16:29 ET
|
Qu Biologics
VANCOUVER, British Columbia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Avantor Opens New Life Sciences Research Center
July 18, 2017 12:03 ET
|
Avantor
CENTER VALLEY, PA--(Marketwired - July 18, 2017) - Avantor®, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, has opened a new...